Microarray Analysis of \u3ci\u3eParamecium bursaria\u3c/i\u3e Chlorella
Virus 1 Transcription by Yanai-Balser, Giane M. et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
James Van Etten Publications Plant Pathology Department
2010
Microarray Analysis of Paramecium bursaria
Chlorella Virus 1 Transcription
Giane M. Yanai-Balser
University of Nebraska-Lincoln
Garry A. Duncan
Nebraska Wesleyan University, gduncan@nebrwesleyan.edu
James D. Eudy
University of Nebraska Medical Center
Dong Wang
University of Nebraska-Lincoln
Xiao Li
University of Massachusetts
See next page for additional authors
Follow this and additional works at: http://digitalcommons.unl.edu/vanetten
Part of the Genetics and Genomics Commons, Plant Pathology Commons, and the Viruses
Commons
This Article is brought to you for free and open access by the Plant Pathology Department at DigitalCommons@University of Nebraska - Lincoln. It
has been accepted for inclusion in James Van Etten Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.
Yanai-Balser, Giane M.; Duncan, Garry A.; Eudy, James D.; Wang, Dong; Li, Xiao; Agarkova, Irina V.; Dunigan, David D.; and Van
Etten, James L., "Microarray Analysis of Paramecium bursaria Chlorella Virus 1 Transcription" (2010). James Van Etten Publications. 1.
http://digitalcommons.unl.edu/vanetten/1
Authors
Giane M. Yanai-Balser, Garry A. Duncan, James D. Eudy, Dong Wang, Xiao Li, Irina V. Agarkova, David D.
Dunigan, and James L. Van Etten
This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/vanetten/1
JOURNAL OF VIROLOGY, Jan. 2010, p. 532–542 Vol. 84, No. 1
0022-538X/10/$12.00 doi:10.1128/JVI.01698-09
Copyright © 2010, American Society for Microbiology. All Rights Reserved.
Microarray Analysis of Paramecium bursaria Chlorella
Virus 1 Transcription†
Giane M. Yanai-Balser,1 Garry A. Duncan,2 James D. Eudy,3 Dong Wang,4 Xiao Li,5
Irina V. Agarkova,1 David D. Dunigan,1,6 and James L. Van Etten1,6*
Department of Plant Pathology, University of Nebraska, Lincoln, Nebraska 68583-07221; Biology Department,
Nebraska Wesleyan University, Lincoln, Nebraska 68504-27942; Department of Genetics, Cell Biology and
Anatomy, University of Nebraska Medical Center, Omaha, Nebraska 68198-54553; Statistics Department,
University of Nebraska, Lincoln, Nebraska 68583-09634; Biomedical Engineering and Biotechnology,
University of Massachusetts, Lowell, Massachusetts 018545; and Nebraska Center for Virology,
University of Nebraska, Lincoln, Nebraska 68583-09006
Received 12 August 2009/Accepted 7 October 2009
Paramecium bursaria chlorella virus 1 (PBCV-1), a member of the family Phycodnaviridae, is a large double-
stranded DNA, plaque-forming virus that infects the unicellular green alga Chlorella sp. strain NC64A. The
330-kb PBCV-1 genome is predicted to encode 365 proteins and 11 tRNAs. To monitor global transcription
during PBCV-1 replication, a microarray containing 50-mer probes to the PBCV-1 365 protein-encoding genes
(CDSs) was constructed. Competitive hybridization experiments were conducted by using cDNAs from poly(A)-
containing RNAs obtained from cells at seven time points after virus infection. The results led to the following
conclusions: (i) the PBCV-1 replication cycle is temporally programmed and regulated; (ii) 360 (99%) of the
arrayed PBCV-1 CDSs were expressed at some time in the virus life cycle in the laboratory; (iii) 227 (62%) of
the CDSs were expressed before virus DNA synthesis begins; (iv) these 227 CDSs were grouped into two classes:
127 transcripts disappeared prior to initiation of virus DNA synthesis (considered early), and 100 transcripts
were still detected after virus DNA synthesis begins (considered early/late); (v) 133 (36%) of the CDSs were
expressed after virus DNA synthesis begins (considered late); and (vi) expression of most late CDSs is
inhibited by adding the DNA replication inhibitor, aphidicolin, prior to virus infection. This study provides the
first comprehensive evaluation of virus gene expression during the PBCV-1 life cycle.
Paramecium bursaria chlorella virus 1 (PBCV-1), the proto-
type of the genus Chlorovirus (family Phycodnaviridae), is a
large, icosahedral (190 nm in diameter), plaque-forming virus
that infects the unicellular, eukaryotic green alga Chlorella sp.
strain NC64A. The PBCV-1 virion has a lipid membrane lo-
cated inside an outer glycoprotein capsid. The 330-kb genome
is a linear, nonpermutated, double-stranded DNA (dsDNA)
molecule with covalently closed hairpin ends that has approx-
imately 365 protein encoding genes (CDSs), as well as 11
tRNA encoding genes (reviewed in references 34, 39, and 40).
The CDSs are evenly distributed on both strands and inter-
genic space is minimal (typically fewer than 100 nucleotides);
the exception is a 1,788-bp sequence in the middle of the
genome that encodes the tRNA genes. Approximately 35% of
the 365 PBCV-1 gene products resemble proteins in the public
databases.
PBCV-1 initiates infection by attaching rapidly and specifi-
cally to the cell wall of its host (22), probably at a unique virus
vertex (4, 26). Attachment is immediately followed by host cell
wall degradation by a virus-packaged enzyme(s) at the point of
contact. After wall degradation, the viral internal membrane
presumably fuses with the host membrane, causing host mem-
brane depolarization (9), potassium ion efflux (25), and an
increase in the cytoplasm pH (2). These events are predicted to
facilitate entry of the viral DNA and virion-associated proteins
into the cell. PBCV-1 lacks a gene encoding a recognizable
RNA polymerase or a subunit of it, and RNA polymerase
activity is not detected in PBCV-1 virions. Therefore, viral
DNA and virion-associated proteins are predicted to migrate
to the nucleus, and early viral transcription is detected 5 to 10
min postinfection (p.i.), presumably by commandeering a host
RNA polymerase(s) (possibly RNA polymerase II) (14, 29).
Virus DNA synthesis begins 60 to 90 min p.i., followed by virus
assembly at 3 to 5 h p.i. in localized regions of the cytoplasm,
called virus assembly centers (21). At 6 to 8 h p.i., virus-
induced host cell lysis occurs resulting in release of progeny
virions (1,000 viruses/cell, 25% of which are infectious).
These events are depicted in Fig. 1.
To initiate PBCV-1 transcription, the host RNA poly-
merase(s), possibly in combination with a virus transcription
factor(s), must recognize virus DNA promoter sequences. Re-
cently, three short nucleotide sequences were identified in pu-
tative virus promoter regions (150 bp upstream and 50 bp
downstream of the ATG translation site) that are conserved in
PBCV-1 and other Chlorovirus members (7). PBCV-1 CDSs
are not spatially clustered on the genome by either temporal or
functional class, suggesting that transcription regulation must
occur via cis- and possible trans-acting regulatory elements.
To understand the dynamics of PBCV-1 global gene expres-
sion during virus replication, we constructed a microarray con-
taining 50-mer probes to each of the 365 PBCV-1 CDSs.
* Corresponding author. Mailing address: Nebraska Center for Vi-
rology, University of Nebraska, Lincoln, NE 68583-0900. Phone: (402)
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cDNAs from poly(A)-containing RNAs isolated from cells at
seven times after PBCV-1 infection were competitively hybrid-
ized against a reference sample on the microarray. To further
delineate early and late gene expression, cells were treated
with the DNA replication inhibitor, aphidicolin, prior to infec-
tion. The results provide the first comprehensive transcrip-
tional map of the virus genome, conferring insights about the
characterization of each PBCV-1 CDS, the majority of which
have unknown functions. In addition, the microarray data sug-
gest that viral DNA replication plays a significant role in the
temporal regulation of gene expression.
MATERIALS AND METHODS
RNA isolation and drug treatment. Chlorella strain NC64A cells (108 cells/ml)
were infected with PBCV-1 at a multiplicity of infection of 5 to ensure synchro-
nous infection. Uninfected cells and cells at 20, 40, 60, 90, 120, 240, and 360 min
p.i. were harvested by centrifugation (4,000 rpm) for 5 min at 4°C and disrupted
with glass beads (0.25 to 0.30 mm in diameter) by using a bead beater (Disruptor
Genie; Scientific Industries, Bohemia, NY) in the presence of TRIzol (Invitro-
gen, Carlsbad, CA). RNAs were isolated by using the Absolutely RNA miniprep
kit (Stratagene, La Jolla, CA) according to the manufacturer’s instructions. RNA
integrity was verified in denaturing 1% agarose gels by monitoring host cytoplas-
mic and chloroplast rRNAs. Total RNA was quantified with a NanoDrop spec-
trophotometer (NanoDrop Technologies, Wilmington, DE).
To determine the effect of virus DNA synthesis on virus gene expression,
aphidicolin (20 g/ml) was added to the cells 15 min prior to infection, and
samples were collected at the same times after infection as described above.
Control samples were obtained from infected nontreated cells at the same times.
Preliminary experiments to determine optimal drug dosage and time of applica-
tion indicated that 20 g of aphidicolin/ml completely inhibits DNA synthesis in
15 min.
Microarray construction and hybridization. The PBCV-1 genome is predicted
to have 365 CDSs and 11 tRNA encoding genes. The tRNAs sequences were not
included in the microarrays. Fifty-mer probes representing each CDS in the
PBCV-1 genome were designed and synthesized by MWG Biotech (Ebersberg,
Germany) (20 to 80% GC, with a melting temperature of 60 to 80°C). A table
with the probes’ sequences is in Supplement S1 in the supplemental material.
Probes were spotted onto CMT-GAPS silane-coated slides (Corning, Lowell,
MA) by using Omnigrid 100 (Genomic Solutions, Ann Arbor, MI) according to
the manufacturer’s instructions. Probes were printed in quadruplicates on every
slide. For each time point, 20 g of total RNA was reverse transcribed by using
oligo(dT) as a primer, and cDNAs were labeled with either Cy3- or Cy5-dUTP
(GE Healthcare, Piscataway, NJ) with the SuperScript indirect cDNA labeling
system (Invitrogen) according to the supplier’s directions. The reference sample,
for the time course experiments, consisted of a pool of transcripts obtained by
mixing equal amounts of total RNA from each time point. Competitive
hybridization experiments were conducted for each sample against the ref-
erence sample (15, 18, 41). For the aphidicolin experiments, a direct com-
parison was carried out with each treated sample versus the corresponding
untreated infected control.
Labeled cDNAs were resuspended in 40 l of preheated (68°C) Ambion
hybridization buffer 2 (Ambion, Austin, TX). Arrays were hybridized (42°C) for
16 h in a Corning hybridization chamber (Corning, Lowell, MA). The slides were
washed twice (42°C) in 2 SSC (1 SSC is 0.15 M sodium chloride plus 0.015 M
sodium citrate)–0.5% sodium dodecyl sulfate (SDS) for 15 min, followed by two
FIG. 1. Timeline representing the PBCV-1 life cycle in Chlorella strain NC64A. Numbers represent minutes after infection. CDSs expressed
before viral DNA synthesis begins were classified as early (black arrow), CDSs expressed after DNA synthesis begins were classified as late (white
arrow), and CDSs expressed before and after DNA synthesis begins were classified as early/late (arrow with diagonal lines). Electron micrographs
A and B were reproduced with permission from Meints et al. (22), and micrographs C and D were reproduced with permission from Meints et
al. (21).
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washes in 0.5 SSC–0.5% SDS for 15 min. Slides were then dried by low-speed
centrifugation and subjected to fluorescence detection with an Axon 4000B
scanner (Molecular Devices, Sunnyvale, CA).
Microarray analysis. Results from three independent experiments were ana-
lyzed by using the GenePix Pro v.6.0 software (Molecular Devices) and TIGR
microarray software suite (TM4) (28). Several transformations were performed
to eliminate low-quality data, to normalize the measured intensities using the
Lowess algorithm, and to regulate the standard deviation of the intensity of the
Cy5/Cy3 ratio across blocks. CDSs that displayed statistically significant modu-
lation were identified by a one-way analysis of variance, using P values of 0.01
as a cutoff. For the aphidicolin experiments, significant analysis of microarray
(33) was used to identify CDSs with statistically significant changes in expression
compared to an untreated infected sample (false discovery rate, 5%). CDSs
with similar expression profiles were grouped into different clusters with a K-
means algorithm by using Euclidean distance and 50 maximum iterations.
PBCV-1 microarray data sets were deposited at NCBI’s Gene Omnibus Express
(GEO) under the accession number GSE18421.
RESULTS AND DISCUSSION
Microarray quality check. To evaluate our probes, equal
amounts of PBCV-1 genomic DNA (2 g) were labeled in two
independent reactions with either Cy3-dCTP or Cy5-dCTP
(GE Healthcare) by using random primers (Invitrogen). The
two reactions were then competitively hybridized with the
probes in the microarray. No difference was detected in hy-
bridization of the two DNA samples on all spots (results not
shown), indicating the probes were specific and also excluding
any preferential hybridization to one of the dyes. In addition,
to check for host cross-hybridization, PBCV-1 DNA (2 g) was
labeled with Cy3-dCTP and host Chlorella strain NC64A DNA
(2 g) with Cy5-dCTP. Only two PBCV-1 CDSs (A260R and
A625R) hybridized with host DNA; however, these two CDS
are false positives since recently available Chlorella strain
NC64A genome sequence did not have detectable homologous
sequences.
PBCV-1 transcription program. RNAs were isolated from
infected cells at 20, 40, 60, 90, 120, 240, and 360 min p.i.
Competitive hybridization results from each time point against
the RNA reference pool revealed that transcripts of 360 (99%)
of the 365 PBCV-1 CDSs display statistically significant varia-
tion in at least one of the experimental time points (Fig. 2).
CDSs A60L, A328L, A482R, and A646L did not pass statistical
tests in the time course experiment. CDS A689L was not spot-
ted onto the array because it was accidentally omitted during
the probe synthesis. The gene expression analysis was based on
relative levels, rather than absolute levels of expression. Map-
ping the PBCV-1 transcription pattern to the genome revealed
no large regions that were biased as to time of expression,
indicating that gene expression in PBCV-1 is mostly controlled
by multiple initiation sites (Fig. 3). However, a few early or late
CDSs clustered in small regions of the genome, as can be seen
in shaded areas in Fig. 3. Interestingly, these small regions are
also clustered and conserved in another sequenced chlorovirus
(NY-2A) that infects the same host chlorella (results not
shown). Unlike the phage T4 genome, where most late CDSs
are located in contiguous regions on the same DNA strand
(18), PBCV-1 expression did not show a strong strand-specific
bias. In addition, there is no relationship between time of
expression and GC content of the genome (Fig. 3).
Classification of PBCV-1 CDSs was based on when the tran-
script was detected by the microarray. Globally, the 360 statis-
tically significant CDSs were grouped into three classes (Fig.
4): (i) 227 (62%) of the CDSs were expressed before viral
DNA synthesis begins at 60 to 90 min p.i.; (ii) these 227 CDSs
were divided into two classes: transcripts of 127 CDSs disap-
peared prior to initiation of virus DNA synthesis (considered
early), while transcripts of 100 CDSs were still detected after
virus DNA synthesis begins (considered early/late); (iii) tran-
scripts of 133 (37%) CDSs were detected after virus DNA
synthesis begins (considered late). Functional categorization of
PBCV-1 CDSs was reported elsewhere (8), and the functional
distribution compared to each transcriptional category is sum-
marized in Fig. 4 and 5. Forty-four of the PBCV-1 encoded
proteins have been expressed, and recombinant proteins were
shown to be functional enzymes. These are indicated with an
asterisk in Fig. 5. The functions of the remaining CDSs are
either putative or unknown.
A previously described putative promoter sequence (AAT
GACA) and a similar sequence (ATGACAA) (7, 14) were
detected in 50 early or early/late PBCV-1 CDSs. However,
promoter sequences for most early, early/late, and late CDSs
remain unidentified.
Early CDSs. A total of 127 (35%) of the 360 PBCV-1 CDSs
were expressed early, 20 to 60 min p.i. (see Supplement S2 in
the supplemental material). Sixty-one percent of the early
CDSs have no known function. Many of the early CDSs are
predicted to encode the machinery for the virus to begin DNA
replication. In fact, PBCV-1 encodes seven proteins involved
in DNA replication, recombination and repair that were ex-
pressed early including:  DNA polymerase (A185R), super-
family III helicase (A456L), DNA topoisomerase II (A583L),
RNase H (A399R), and PCNA (A574L). A pyrimidine dimer-
specific glycosylase (A50L), a well-characterized DNA repair
enzyme involved in pyrimidine photodimer excision (20), was
also expressed early. Additional PBCV-1 encoded proteins
involved in virus DNA synthesis and DNA recombination were
in the early/late class including, DNA primase (A468R), a 5-3
exonuclease (A166R) and a second PCNA (A193L). The
PBCV-1 genome contains methylated nucleotides, both N6-
methyl adenine and 5-methylcytosine (35). Therefore, it is not
surprising that the virus encodes three functional DNA meth-
yltransferases that were transcribed early: two enzymes that
form N6-methyladenine (A251R and A581R) and one that
forms 5-methylcytosine (A517L).
PBCV-1 DNA synthesis also requires large quantities of de-
oxynucleotide triphosphates (dNTPs) that cannot be accounted
for simply by recycling deoxynucleotides from host DNA. By
4 h p.i., the total amount of DNA in the cell increases fourfold
due to viral DNA synthesis (37). To guarantee a supply of
dNTPs in nonproliferating host cells, large DNA viruses, in-
cluding PBCV-1, encode proteins involved in dNTP biosynthe-
sis: dUTP pyrophosphatase (A551L), thioredoxin (A427L),
thymidylate synthase X (A674R), and cytosine deaminase
(A200R) CDSs were transcribed early. Additional dNTP syn-
thesizing CDSs in the early/late class included aspartate tran-
scarbamylase (A169R), both subunits of ribonucleotide reduc-
tase (A476R and A629R), glutaredoxin (A438L), and dCMP
deaminase (A596R).
Several PBCV-1 CDSs predicted to encode proteins in-
volved in transcription were also expressed early. These pro-
teins included three putative transcription factors (TFIIB
[A107L], TFIID [A552R], and TFIIS [A125L]), two helicases
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FIG. 2. Heat map illustrating the expression of 360 PBCV-1 CDSs during the infection cycle. cDNAs from each time point were labeled with
Cy5, and the reference control was labeled with Cy3. Color code represents the log2 (Cy5/Cy3) ratio for each time point. CDSs with similar
expression profiles were grouped into three classes representing early, early/late, and late by using a K-means algorithm. Each column corresponds
to the time point when total RNA was collected (numbers represent minutes after infection). Each row represents a different CDS in PBCV-1.
A list of all of the CDSs is available in Supplement S2 in the supplemental material.
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(SWI/SNF helicase [A548L] and superfamily II helicase
[A241R]), and RNase III (A464R). The genes for two enzymes
involved in mRNA capping, an RNA triphosphatase (A449R)
and a guanylyltransferase (A103R), were also transcribed
early. The products of at least some of these early CDSs are
undoubtedly involved in the switching of virus early gene tran-
scription to late gene transcription.
A few PBCV-1 enzymes involved in protein synthesis and
protein degradation were transcribed early, including transla-
tion elongation factor-3 (A666L), ubiquitin C-terminal hydro-
lase (A105L), Skp1 protein (A39L), SCF-E3 ubiquitin ligase
(A481L), a zinc metallopeptidase (A604L), and an ATPase
(AAA  class) (A44L).
Unlike other viruses, PBCV-1 encodes at least part, if not all, of
the machinery required to glycosylate its major capsid protein
(19), including five glycosyltransferases (11, 38, 43). Further-
FIG. 3. Mapping of the PBCV-1 transcriptome. Blue arrows, early CDSs; green arrows, early/late CDSs; red arrows, late CDSs. Arrow points
indicate the transcription direction. Shaded areas indicate small transcription CDS clusters that are also conserved in another chlorovirus (NY-2A),
except for the areas marked with asterisks. The middle circle shows the GC content of the genome. Note that the PBCV-1 genome is linear, and
a circular map was generated for illustration purposes only.
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more, glycosylation of the virus major capsid protein probably
occurs independently of the host endoplasmic reticulum-Golgi
system (19). All of the glycosyltransferase CDSs were ex-
pressed early (A64R, A111/114R, A219/222/226R, A473L, and
A546L).
The chlorella viruses are also unusual because they encode
enzymes involved in sugar metabolism. Two PBCV-1-encoded
enzymes synthesize GDP-L-fucose from GDP-D-mannose,
GDP-D-mannose dehydratase (A118R), and fucose synthase
(A295L) (10, 32) and three enzymes, glucosamine synthetase
(A100R), UDP-glucose dehydrogenase (A609L), and hyaluro-
nan synthase (A98R), contribute to the synthesis of hyaluro-
nan, a linear polysaccharide composed of alternating -1,4-
glucuronic acid and -1,3-N-acetylglucosamine residues (6,
16). The CDSs for these five enzymes were expressed early.
Early/late CDSs. A total of 100 (27%) CDSs were classified
as early/late, 67 (67%) of which have unknown function (see
Supplement S2 in the supplemental material). This class con-
tains CDSs that were expressed before 60 min p.i., but whose
transcripts were also present after PBCV-1 DNA synthesis
begins. At least three mechanisms can lead to classification of
CDSs into the early/late class: (i) the CDSs were transcribed
both before and after viral DNA replication begins; (ii) the
CDSs were only transcribed prior to initiation of virus DNA
synthesis, but complete degradation of their transcripts only
occurred after DNA synthesis begins; and (iii) the CDSs en-
code polycistronic mRNAs, e.g., one could have a dicistronic
mRNA in which one CDS is required for an early function and
the other CDS is required for a late function. To add to the
complexity, 30 transcripts were detected early, disappeared,
FIG. 4. (A) PBCV-1 global expression pattern. (B) Distribution of CDSs according to their putative function and time of expression. CDS
products with unknown function are not listed in this graph.
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and then reappeared as late transcripts (these CDSs are
marked in Supplement S2 in the supplemental material). A
similar phenomenon has been reported in transcriptional stud-
ies with the bacteriophage T4 (18) and Red Sea bream iridovi-
rus (17).
In addition to the early/late CDSs described in the preceding
section, the most striking feature of this early/late class was the
presence of many genes encoding proteins associated with
genome integration, including five GIY-YIG endonucleases
(A134L, A287R, A315L, A495R, and A651L) and four HNH
endonucleases (A354R, A422R, A478L, and A490L). Also,
one of the two transposases (A366L) coded by PBCV-1 was
expressed early/late. The functions of these proteins in the
PBCV-1 life cycle are unknown.
Late CDSs. A total of 133 (37%) of the 360 CDSs were
classified as late CDSs (see Supplement S2 in the supplemental
material), 74% of which have no match in the public databases.
The expectation is that most late CDS products are involved in
either virus capsid assembly, DNA packaging, or virus release
or are packaged in the virus particles. Indeed, an SDS-poly-
acrylamide gel electrophoresis mass spectrometry proteomic
analysis of purified virions indicated that 118 PBCV-1 gene
products were detected in the virions (D. D. Dunigan et al.,
unpublished results). Of these 118 proteins, 83 had their cor-
responding CDS transcribed late, 29 were transcribed early/
late, while only 6 virion-associated proteins were expressed
early.
At least nine late CDSs are predicted to have their gene
products serving a purely structural role in the virion including
the major capsid protein A430L (12) and A140/145R, which is
associated with the unique vertex of the virus (26). Other
putative structural proteins are A189/192R, A363R, A384L,
A540L, A558L, A561L, and A622L. Homologs of all of these
proteins are present in all of the chloroviruses (Dunigan et al.,
unpublished). In addition to structural proteins, a DNA-bind-
ing protein (A437L), predicted to aid in neutralization of the
virus dsDNA, was in the virion, and its gene was transcribed
late.
Several CDSs encoding proteins with putative enzyme func-
tions were expressed late, and their gene products were pack-
aged in the PBCV-1 virion. Presumably, these enzymes are
released into the cell during virus infection and aid in estab-
lishing infection. These proteins include an ATPase (A561L),
a superfamily II helicase (A363R), a SWI/SNF chromatin re-
modeling complex subunit (A189/192R), and a SET domain-
containing histone 3, Lys27 methyltransferase (named vSET)
(A612L). The vSET protein is predicted to aid in the rapid
inhibition of host transcription during virus infection (24). Two
site-specific (restriction) endonucleases (A252 and A579L)
were also expressed as late CDSs, and their proteins are pack-
FIG. 5. Heat map showing distribution of selected CDSs according to their putative functional class. cDNAs from each time point were labeled
with Cy5, and the reference control was labeled with Cy3. The color code represents the log2 (Cy5/Cy3) ratio for each time point. Each column
corresponds to the time point when total RNA was collected (numbers represent minutes after infection). Each row represents a different PBCV-1
CDS. Recombinant proteins have been characterized for the CDSs marked with an asterisk.
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aged in the virion. The restriction endonucleases are involved
in host chromosome degradation, which begins within a few
minutes after virus infection (1). Thus, PBCV-1 has at least
two avenues to inhibit host transcription and subvert the host
RNA polymerase (presumably RNA polymerase II) for virus
transcription: virus packaged restriction endonucleases and a
vSET histone 3, Lys27 methyltransferase.
Five of the eight PBCV-1-encoded Ser/Thr protein kinase
CDSs were expressed late (A34R, A277L, A278L, A282L, and
A614L). With the exception of A277L, the other four kinases
were packaged in the virion (Dunigan et al., unpublished). A
dual specific phosphatase (A305L) was also expressed late, and
the protein is present in the virion. These results indicate that
PBCV-1 has the potential to release several protein kinase/
phosphatase proteins into the cell during infection; these en-
zymes are probably involved in regulatory mechanisms.
PBCV-1 encodes five proteins that degrade polysaccharides,
and presumably some of these encoded proteins are involved
in host cell wall degradation either during virus entry or in
aiding lysis of the cell wall during virus release (30). With the
exception of  1,3-glucanase (A94L) that was expressed early,
the remaining four CDSs were transcribed late. The late CDSs
encode a - and 	-1,4-linked glucuronic lyase (A215L), two
chitinases (A260R and A181/182R), and one chitosanase
(A292L).
Finally, 49 late gene products were not detected in the
virion. Fifteen of these proteins have a putative function in-
cluding, for example, a DNA packaging ATPase (A392R) that
is predicted to be involved in packaging DNA into the virion.
Interestingly, some CDSs that were expected to be transcribed
early because of their putative involvement in the DNA repli-
cation were transcribed late. These CDSs encode a replication
factor C protein (A417L), which is similar to one of the two
replication factor C proteins in Archaea, an ATP-dependent
DNA ligase (A544R), and a deoxynucleoside kinase (A416R).
However, none of these proteins were detected in the virion
(Dunigan et al., unpublished).
Aphidicolin treatment. To confirm the early and late classi-
fication of PBCV-1 CDSs, aphidicolin was used to block viral
DNA synthesis. The drug was added to the culture 15 min prior
to the addition of PBCV-1, and cells were harvested at the
same times after infection used in the previous experiments
(20, 40, 60, 90, 120, 240, and 360 min p.i.). Each sample was
analyzed by using the corresponding infected nontreated sam-
ple as a control.
Expression of 179 (49%) CDSs was inhibited by aphidicolin
(see Supplement S2 in the supplemental material). Of these
179, 14 were expressed early, 57 were expressed early/late, and
108 were expressed late. This experiment established that tran-
scription of most late CDSs relies on the synthesis of viral
DNA. In contrast, expression of 181 CDSs was not affected by
aphidicolin. Of these 181, 113 were early, 43 were early/late,
and 25 were late. Three CDSs (A328R, A482R, and A464L)
were not previously classified as early, early/late, or late be-
cause they did not pass statistical tests. However, they were
expressed in the presence of aphidicolin, which indicates that
these CDSs might be early. Collectively, expression of most
early CDSs was not affected by aphidicolin and expression of
late CDSs was inhibited by the drug. We have no explanation
for why 14 early CDSs and 57 early/late CDSs were affected by
aphidicolin, nor do we know why 25 late CDSs were not af-
fected by aphidicolin.
Verification of the microarray results. Three independent
sets of experiments support the microarray results. (i) Recom-
binant proteins from 19 PBCV-1 CDSs have been biochemi-
cally characterized previously, and their genes were Northern
blotted to determine when they were expressed. Sixteen of
these results completely agree with the microarray experi-
ments. The other three Northern analyses were similar, but not
identical, to the microarray analyses. One is a glycosyltrans-
ferase (A64R), which Northern analysis indicated is expressed
from 45 to 360 min p.i. (11), whereas the microarray analysis
indicated that the CDS was expressed only between 40 and 60
min p.i. The second CDS is a chitinase (A181/182R), which
Northern results indicate transcription occurs between 30 and
360 min p.i. (30), whereas the microarray analysis showed the
transcript was present from 60 to 360 min p.i. The third CDS
is a dCMP deaminase (A596R), which Northern analysis indi-
cated expression occurs from 30 to 120 min p.i. (42); the mi-
croarray experiments detected the transcript at 40 to 60 min
p.i. and then again from 240 to 360 min p.i. This discontinuity
in expression has also been observed with a few other virus
CDSs, and it has been observed in both Northern blots and
in the microarray results (e.g., ornithine/arginine decarboxyl-
ase [A207R] [23]). It is important to note that the microarrays
measured relative levels of the transcript, and this fact could
explain the few differences mentioned above.
(ii) The 46.2-Mb genome of the PBCV-1 host, Chlorella
NC64A, was recently sequenced to ninefold coverage (http:
//genome.jgipsf.org/ChlNC64A_1/ChlNC64A_1.info.html). This
prompted us to initiate a transcriptome analysis of Chlorella
NC64A and PBCV-1-infected cells by shotgun sequencing
cDNA derived from poly(A) RNA using a new high-through-
put sequencing instrument. To date, we have two sets of se-
quences, one from uninfected Chlorella NC64A and one from
cells at 20 min p.i. We compared the 20-min p.i. viral microar-
ray results with the infected 20-min p.i. viral transcriptome
sequencing results. Of the 172 CDSs detected by the microar-
ray analysis at 20 min p.i., expression of 159 CDSs (92%) were
detected in the transcriptome study using a 200-fold coverage
cutoff (G. M. Yanai-Balser et al., unpublished results).
(iii) Kawasaki et al. (14) identified 22 immediate-early
PBCV-1 CDSs (expressed at 5 to 10 min p.i.). Our microarray
results indicated that 20 of these 22 CDSs were expressed
early. CDS A689L was not present in our array, and CDS
A312L was classified as early/late and was not detected at 20
min p.i., which is the earliest time point in the present study. In
the later case, the difference could be due to the relative
measurement of the transcript.
Do late PBCV-1 mRNAs have a poly(A) tail? Both the mi-
croarray results and the preliminary transcriptome sequenc-
ing of PBCV-1 depended on cDNA synthesis using an oli-
go(dT) primer. We mention this issue for two reasons. First,
about 20 years ago we conducted a set of pulse-labeling exper-
iments wherein PBCV-1-infected cells were incubated with
[H3]adenine for 30-min periods (36). Poly(A) and poly(A)

RNAs were separated on an oligo(dT)-cellulose column, and
the radioactivity was determined. The results indicated that 22
to 26% of the radioactivity eluted in the poly(A) fraction
from cells infected from 0 to 30 min and from 30 to 60 min p.i.
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In contrast, 6.1, 4.5, and 2.5% of the radioactivity eluted in the
poly(A) fractions at 60 to 90, 90 to 120, and 120 to 240 min
p.i., respectively. Therefore, we suggested that PBCV-1 early
mRNAs probably contain poly(A) tails and late mRNAs might
lack them. However, there are other explanations for these
earlier results, e.g., the pool size of unlabeled adenine certainly
increases dramatically during infection; consequently, there
could be a large dilution effect on the added [H3]adenine
compared to the controls. In addition, we now know that
PBCV-1 infection leads to rapid depolarization of the host
plasma membrane, which causes an immediate decrease in
adenine transport into the infected cell (2). Both of these
issues undoubtedly influenced our previous results.
Second, a report by Kawasaki et al. (14) also suggests that
there may be a shift in poly(A) RNAs during chlorella virus
replication. Twenty-two PBCV-1 immediate-early CDSs were
analyzed, and the transcripts gradually decreased in size after
20 min p.i., suggesting weakening or cessation of poly(A) poly-
merase activity.
The current manuscript provides evidence that most, if not
all, PBCV-1 mRNAs have a poly(A) tail because expression of
99% of the PBCV-1 CDSs was detected in our microarray
experiments. Furthermore, many of the CDSs we identified
were clearly expressed late and packaged in the virion.
PBCV-1 transcription is complex. As mentioned above, we
and others have characterized several individual PBCV-1 gene
products. In most of these reports, a Northern analysis was
conducted when studying a specific CDS. The transcription
patterns of 50% of these CDSs are more complicated than
just obtaining a single hybridizing RNA band of the predicted
size at specific times. That is, full-length gene DNA probes
often hybridize to mRNA transcripts that are 40 to 60% larger
than the CDS itself, suggesting that PBCV-1 might have poly-
cistronic mRNAs. In addition, some probes not only hybridize
to mRNAs of the expected size, but they also hybridize to
larger mRNAs at other times in the virus replication cycle.
These complex patterns occur even with single-stranded DNA
probes (e.g., the potassium ion channel CDS, kcv) (13). One
difference between the previous Northern analyses and the
microarray results is that hybridization to total RNA was used
in the Northern analyses and in the research described in the
present study the cDNAs were synthesized from poly(A)
RNAs.
We examined four of the CDSs that produced larger tran-
scripts than expected to determine whether expression of their
flanking CDSs were identical in the microarray experiments to
the target CDS, possibly suggesting a polycistronic mRNA. A
common expression pattern was obtained for two of the four
CDSs. The RNase III (A464R) mRNA has a predicted size of
825 nucleotides (nt). However, in a Northern blot the RNase
III hybridizing band is 1,300 nt. Its two adjacent CDSs are
204 nt (A462R) and 354 nt (A465R) and, like A464R, both of
them are expressed early. The combined sizes of them with the
RNase III CDS are compatible with either a dicistronic or even
a tricistronic mRNA. The other example is the potassium ion
channel CDS (kcv, A250R) that Northern analysis indicated
has a complex expression pattern, at early times A250R is
expressed as a large message and at late stages as a monocis-
tronic mRNA (13). However, when the early transcript for this
CDS was mapped, the start and the stop sites were within the
adjacent CDSs, so A250R is clearly not a polycistronic mRNA.
The CDSs surrounding the other two CDSs with larger tran-
scripts than expected, fucose synthase (A295L) and dCMP
deaminase (A596R), were expressed at different times than the
target CDS.
It is clear that a detailed transcription analysis using a high-
throughput sequencing system of PBCV-1-infected cells will be
required to precisely determine promoter and terminator sites,
as well as splicing regions of PBCV-1 transcription. This anal-
ysis should include the use of random primers in addition to
oligo(dT) primers and also allow the detection of PBCV-1
encoded small RNAs.
Microarray results with other large dsDNA viruses.
PBCV-1 expressed 99% of its CDSs at some point in the virus
life cycle during infection in laboratory conditions. Similar
results were obtained for other large DNA viruses such as
vaccinia virus and monkeypox viruses in which 95% of their
CDSs are expressed in cell cultures (3, 27). Transcription anal-
ysis using microarrays was also performed with two marine fish
iridoviruses: (i) Singapore grouper iridovirus expressed 97% of
its CDSs in cell culture (31), and (ii) Red Sea bream iridovirus
expressed 96% of its CDSs during in vitro infection (17).
Therefore, it appears that most CDSs are expressed in these
large dsDNA viruses, even in laboratory conditions.
The temporal categorization of the transcripts in large vi-
ruses varies. Different studies classify virus transcripts in dif-
ferent ways, usually subdividing early CDSs into more specific
categories. For example, Red Sea bream iridoviruses has 9%
of its CDSs classified as immediate-early, 43% classified as
early, and 41% classified as late (17). T4 bacteriophage tran-
scripts are divided into immediate-early (42%), delayed early
(12%), middle early (21%), and late (22%) (18). Poxvirus
transcription occurs in the cytoplasm of the infected cell and is
programmed by a virus-encoded RNA polymerase and time-
specific transcription factors to generate three transcription
categories: early, intermediate, and late (5). Using tiling array
technology, a recent study reveals immediate-early transcripts
in vaccinia virus (3). An additional microarray-based classifi-
cation of vaccinia virus and monkeypox virus gene expression
divided the virus CDSs into early and late categories only
(50% of the CDSs in each class). The method used in this
later study categorized CDSs according to the time the tran-
script is first detected, so the intermediate class (expressed
early and also late) was not distinguished, implying that this
class was a subgroup of the early CDSs (27). For PBCV-1, we
classified a portion of the early CDSs as early/late when the
transcripts were detected before and after the onset of viral
DNA synthesis.
Conclusion. For the first time, a global mRNA transcription
profile was conducted for a chlorella virus. The PBCV-1 life
cycle is temporally programmed. This regulation is controlled
by a precise gene expression pattern, where the time of tran-
scription is dictated by initiation of viral DNA replication,
which begins 60 to 90 min p.i. Early CDSs were transcribed
between 20 and 60 min p.i., and products of the majority of the
early CDSs are responsible for providing the machinery for
viral DNA replication. Late CDSs were transcribed after 60
min p.i., and most of them were dependent on initiation of viral
DNA synthesis, since aphidicolin blocked the expression of
most late CDSs. Products of many late CDSs serve either a
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structural role or were packaged in the virion, presumably to
aid in virus infection. A total of 46% of the early transcripts
were still detected after DNA synthesis begins and were called
early/late CDSs, indicating a complex mechanism for mRNA
maturation and degradation. Some of these early/late CDSs
may only be synthesized early, but their transcripts were not
degraded until after DNA synthesis begins. However, this sce-
nario probably does not apply to all early/late CDSs because
several early-late CDS products were packaged in the virion.
These CDSs may also be transcribed as late CDSs.
The present study reveals that PBCV-1 gene expression time
is independent of GC content, as well as the transcription
direction and CDS location in the genome. It is anticipated
that the temporal transcription map will provide clues to the
functions of the large category of viral proteins whose func-
tions are not yet known and to the events that must be orches-
trated for a successful viral infection.
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